Severe Asthma, Scichilone (Sip-Irs): ...Facilitate Access to Innovative Centers and therapies...
5 Articles
5 Articles
In recent years we have seen an increase in the possibility of effective intervention in the management of severe asthma thanks to the progress in the development of new therapies, especially biological. Therapeutic innovation has allowed us to meet the needs of our patients but remains critical. Thus Nicola Scichilone, elected president of Sip-Irs, Italian company [...]
In recent years we have seen an increase in the possibility of effective intervention in the management of severe asthma thanks to the progress in the development of new therapies, especially biological. Therapeutic innovation has allowed to meet the needs of our patients but remain critical. Thus Nicola Scichilone, elected president of the Sip-Irs, Italian company [...] L'articolo Asma grave, Scichilone (Sip-Irs): "Facilitate access to innovati…
“The therapeutic innovation of recent years has made it possible to meet the needs of our patients, but obviously some critical issues remain. These also concern access to reference centers dedicated to the management of this disease, access that should be facilitated to intervene not only on patients' quality of life, but also on the course itself and on the natural history of the disease.” This was stated by Nicola Scichilone, elected presiden…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium






